ArticleMolecular cancer2014

Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy.

Li-Sheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.